CAPITAL IMPACT ADVISORS, LLC – Allogene Therapeutics, Inc. Transaction History
CAPITAL IMPACT ADVISORS, LLC portfolio value:
$196,000
portfolio value
CAPITAL IMPACT ADVISORS, LLC quarter portfolio value change:
-5.26%
quarter
Allogene Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +24.45% | 3.83K shares | 17K | $10.8 | 19.53K |
| Q2 2022 | share | Increase | 0.00% | 15.7K shares | 179K | $11.4 | 15.7K |
| Q1 2021 | share | Decrease | -100.00% | -41.8K shares | -1.05M | $35.3 | 0 |
| Q4 2020 | share | Decrease | -67.14% | -85.39K shares | -3.74M | $25.24 | 41.8K |
| Q3 2020 | share | Increase | +241.96% | 90K shares | 3.20M | $37.71 | 127.19K |
| Q2 2020 | share | Decrease | -52.64% | -41.33K shares | 66K | $42.82 | 37.19K |
| Q1 2020 | share | Increase | +4.13% | 3.11K shares | -432K | $19.44 | 78.53K |
| Q4 2019 | share | 0.00% | 0 shares | -96K | $25.98 | 75.41K | |
| Q3 2019 | share | Increase | +16.63% | 10.75K shares | 334K | $27.26 | 75.41K |
| Q2 2019 | share | Increase | 0.00% | 64.66K shares | 1.72M | $26.85 | 64.66K |